Therapeutic vaccination refocuses t-cell responses towards conserved regions of HIV-1 in early treated individuals (BCN 01 study)

<p><strong>Background:</strong> Strong and broad antiviral T-cell responses targeting vulnerable sites of HIV-1 will likely be a critical component for any effective cure strategy.</p> <p><strong>Methods:</strong> BCN01 trial was a phase I, open-label, non-r...

Full description

Bibliographic Details
Main Authors: Mothe, B, Manzardo, C, Sanchez-Bernabeu, A, Coll, P, Morón-López, S, Puertas, MC, Rosas-Umbert, M, Cobarsi, P, Escrig, R, Perez-Alvarez, N, Ruiz, I, Rovira, C, Meulbroek, M, Crook, A, Borthwick, N, Wee, EG, Yang, H, Miró, JM, Dorrell, L, Clotet, B, Martinez-Picado, J, Brander, C, Hanke, T, BCN 01 study group
Format: Journal article
Published: Elsevier 2019